Scholarlink

Background and purpose <p>This study responds to the pressing need for novel therapeutic strategies to address key challenges in non-small cell lung cancer (NSCLC) treatment. It explores effective traditional Chinese medicine, investigates its molecular mechanism, and pursues the modernization of traditional Chinese medicine. The current research investigated how Solasonine (SS) extracted from <i>Solanum nigrum L.</i> may counter NSCLC by activating the ferroptosis pathway, while also elucidating the fundamental molecular mechanisms involved.</p> Methods <p>Proliferation (CCK8) and metastasis (wound healing) of A549/HCC1833 cells were assessed. Reactive oxygen species (ROS) production, proteomic sequencing, co-immunoprecipitation (Co-IP), and molecular docking mechanisms of the SS treatment group were analyzed. SLC7A11 regulation was evaluated using ferroptosis inhibitors and by ubiquitination assays. SS efficacy was tested in a subcutaneous/lung metastasis nude mouse model.</p> Results <p>SS suppressed NSCLC proliferation/metastasis by inducing ferroptosis. Proteomics revealed SS downregulated ferroptosis-related proteins and SLC7A11. SS promoted SLC7A11 ubiquitination/degradation via USP10/TRIM25 interactions, confirmed by Co-IP/docking. In vitro/vivo, SS increased ROS, inhibited tumor growth/metastasis, and activated ferroptosis pathways (reduced SLC7A11/GPX4/GSR/GSS). Immunohistochemistry confirmed the presence of ferroptosis markers in tumors.</p> Conclusion <p>SS triggers ferroptosis in NSCLC by disrupting USP10/TRIM25-mediated SLC7A11 stability. This study proposes a novel treatment strategy for NSCLC with a traditional Chinese medicine monomer.</p> Graphical Abstract <p>The graphical abstract of the present study. Solasonine, as one of the most important components of <i>Solanum nigrum L.</i>, competitively binds to SLC7A11 with the deubiquitinating enzyme USP10, thereby promoting TRIM25 to bind to SLC7A11 and causes SLC7A11 to be ubiquitinated and degraded by TRIM25, stimulating ROS production and causing ferroptosis to inhibit the malignant progression of NSCLC.</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Solasonine inhibits NSCLC malignant progression by regulating SLC7A11 ubiquitination degradation and inducing ferroptosis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月28日

查看全文
  • Yuhan Wang,
  • Xiaodan Li,
  • Chuanqiang Zhou,
  • Minxuan Qian,
  • Zhangyan Zou,
  • Wenhui Yang,
  • Nodem Saha Joel Wilfred,
  • Gang Huang,
  • Xianghuai Xu,
  • Fengfeng Xue,
  • Mingming Jin

摘要

Background and purpose

This study responds to the pressing need for novel therapeutic strategies to address key challenges in non-small cell lung cancer (NSCLC) treatment. It explores effective traditional Chinese medicine, investigates its molecular mechanism, and pursues the modernization of traditional Chinese medicine. The current research investigated how Solasonine (SS) extracted from Solanum nigrum L. may counter NSCLC by activating the ferroptosis pathway, while also elucidating the fundamental molecular mechanisms involved.

Methods

Proliferation (CCK8) and metastasis (wound healing) of A549/HCC1833 cells were assessed. Reactive oxygen species (ROS) production, proteomic sequencing, co-immunoprecipitation (Co-IP), and molecular docking mechanisms of the SS treatment group were analyzed. SLC7A11 regulation was evaluated using ferroptosis inhibitors and by ubiquitination assays. SS efficacy was tested in a subcutaneous/lung metastasis nude mouse model.

Results

SS suppressed NSCLC proliferation/metastasis by inducing ferroptosis. Proteomics revealed SS downregulated ferroptosis-related proteins and SLC7A11. SS promoted SLC7A11 ubiquitination/degradation via USP10/TRIM25 interactions, confirmed by Co-IP/docking. In vitro/vivo, SS increased ROS, inhibited tumor growth/metastasis, and activated ferroptosis pathways (reduced SLC7A11/GPX4/GSR/GSS). Immunohistochemistry confirmed the presence of ferroptosis markers in tumors.

Conclusion

SS triggers ferroptosis in NSCLC by disrupting USP10/TRIM25-mediated SLC7A11 stability. This study proposes a novel treatment strategy for NSCLC with a traditional Chinese medicine monomer.

Graphical Abstract

The graphical abstract of the present study. Solasonine, as one of the most important components of Solanum nigrum L., competitively binds to SLC7A11 with the deubiquitinating enzyme USP10, thereby promoting TRIM25 to bind to SLC7A11 and causes SLC7A11 to be ubiquitinated and degraded by TRIM25, stimulating ROS production and causing ferroptosis to inhibit the malignant progression of NSCLC.